Recent Advances in Targeting the HIV-1 Tat/TAR Complex

Area of Science:

• Molecular Biology
• Virology
• Drug Discovery

Background:

• The HIV-1 TAR (Trans-Activation Response) element is a critical cis-acting regulatory RNA motif.
• TAR, along with the viral Tat protein, controls HIV-1 genomic RNA synthesis.
• Targeting the Tat/TAR axis has been a long-standing goal for HIV therapeutics.

Purpose of the Study:

• To review recent strategies for targeting the HIV-1 TAR element.
• To discuss novel agents, including small molecules, peptides, and evolved proteins.
• To highlight the renewed interest in Tat/TAR targeting for HIV cure research.

Main Methods:

• Review of recent literature on small molecule screening against HIV-1 TAR.
• Analysis of studies involving peptide-based inhibitors of the Tat/TAR interaction.
• Examination of approaches using evolved proteins or aptamers to target TAR.
• Discussion of high-throughput technologies and advancements in RNA biology.

Main Results:

• Identification of various classes of small molecules, peptides, and engineered proteins with potential to inhibit TAR function.
• Demonstration of enhanced potency and selectivity of novel agents against regulatory RNAs.
• Progress in understanding RNA biology enabling the discovery of new therapeutic strategies.

Conclusions:

• Targeting the HIV-1 Tat/TAR complex remains a promising avenue for developing novel anti-HIV therapeutics.
• Advances in technology and RNA biology are facilitating the discovery of potent and selective agents.
• These strategies hold potential for impairing virus reactivation and reducing the latent HIV reservoir.